DWP712

botulinum toxin type A · Daewoong Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DWP712, covering 2025-06-10 to 2025-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines [Phase 3]